-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Latest From Biotech Now
Cranial Connections: Ontario’s Brain Research is Hardwired for Success
Ontario has long been a leader in life sciences research and technology with brain exploration now taking centre-stage. Most recently, the provincial government committed $100 million to the Ontario Brain Institute, (OBI). An independent nonprofit formed in 2010, the OBI will help researchers and business leaders develop new treatments for neurological conditions ranging from Alzheimer’s and Parkinson’s to intractable epilepsy, cerebral palsy, autism and attention deficit and hyperactivity disorder. Headquartered in Toronto – a region that Read More >
The Week Ahead for Partnering
As mentioned in our twitter feed, BIO Business Forum and Exhibitor Partnering has surpassed the number of requests in the system over last year’s totals. Over 130,000 partnering meeting requests are off in cyberspace, and close to 22,000 meetings already scheduled. This includes about 4,900 exhibitor partnering meetings, which is another stat beating last year’s numbers. We’ve been excited about the addition of exhibitor partnering, and it’s been great to see the adoption by the exhibitors themselves. Read More >
Jay Keasling Wins BIO’s George Washington Carver Award
BIO announced today that it will honor Jay Keasling, a professor of biochemical engineering at University of California, Berkley; associate laboratory director at Lawrence Berkeley National Laboratory; CEO of the Joint BioEnergy Institute; and Director of Synthetic Biology Engineering Research Center, as the recipient of its 2013 George Washington Carver Award for innovation in industrial biotechnology. The award honors the vision of Carver, an originator of the “chemurgy” movement who, more than a century ago, achieved world Read More >
The UK at BIO
There are more than 400 delegates from the UK attending the 2013 BIO International Convention. These include delegates from four innovative life science companies – Abcodia, Critical Pharmaceuticals, Nanomerics, and PsiOxus Therapeutics – who won the recent UK Trade and Investment (UKTI) Innovation Competition and will showcase their technologies to an international audience in Chicago. The UK presence at the convention will be centred on the UK pavilion (stand 4441) hosted by the BioIndustry Association (BIA) Read More >
How BIO Helps Save Biotech Companies Money
We all know that economic conditions and policy can affect the growth rate and sustainability of companies within the biotech industry. Whether a company is seeking an investment deal, creating partnership opportunities, or applying for FDA approval, BIO’s goal is to create avenues that will support the innovation of its member companies. While some folks within the BIO organization focus on BIO’s mission by providing policy, advocacy and communication services, the Business Solutions team, simply Read More >
